Can a new experimental pill be safely given to people?

NCT ID NCT07757152

Recruiting now Knowledge-focused Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This early-stage trial is testing an experimental tablet called ZL-65 in healthy adults aged 18 to 45. The main goal is to see if the drug is safe and tolerable when given as a single or multiple doses, and to learn how the body absorbs and processes it. The study also looks at whether taking the tablet with food changes how it works. Participants receive either ZL-65 or a placebo, and researchers monitor for any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ZL-65 tablet
What this could lead to: If successful, this early study could pave the way for further development of ZL-65 as a potential treatment for future conditions.
What could go wrong: This is a very early Phase 1 trial in a small number of healthy volunteers, so it primarily checks safety and dosing. The drug may not show the desired effects or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS STUDY

Contacts and locations

Locations

Chengdu Xinhua Hospital
RECRUITING

Chengdu, Sichuan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.